Seeing Is Believing
Currently out of the existing stock ratings of Jo Walton, 1 are a HOLD (50%), 1 are a SELL (50%).
Analyst Jo Walton, currently employed at UBS, carries an average stock price target met ratio of 100% that have a potential upside of 21.29% achieved within 410 days. Previously, Jo Walton worked at CREDIT SUISSE.
Jo Walton’s has documented 4 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MOLN, Molecular Partners AG ADR at 27-Apr-2022.
Analyst best performing recommendations are on MOLN (MOLECULAR PARTNERS AG ADR).
The best stock recommendation documented was for MOLN (MOLECULAR PARTNERS AG ADR) at 1/14/2022. The price target of $25.1 was fulfilled within 35 days with a profit of $6.79 (21.29%) receiving and performance score of 6.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Jun-2021
$13
$9.2 (242.11%)
$13
5 months 3 days ago
(22-Apr-2026)
1/4 (25%)
$8.66 (199.54%)
204
Hold Since 18-Mar-2022
$3.75
$-0.05 (-1.32%)
$4
9 months 17 days ago
(08-Dec-2025)
4/5 (80%)
$-0.45 (-10.71%)
63
Hold Since 29-Aug-2022
$8
$3.67 (84.76%)
4 years 27 days ago
(29-Aug-2022)
1/2 (50%)
$1.92 (31.58%)
661
Hold Since 25-May-2022
$8.28
$4.23 (104.44%)
4 years 4 months ago
(25-May-2022)
1/1 (100%)
$1.42 (20.70%)
757
Sell Since 27-Apr-2022
$10.36
$6.03 (139.26%)
$25.1
4 years 4 months 29 days ago
(27-Apr-2022)
2/2 (100%)
$1.66 (19.08%)
410
What Year was the first public recommendation made by Jo Walton?